Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 8026 AL 8040

Brain photobiomodulation: a potential treatment in Alzheimer's and Parkinson's diseases

Blivet G, Touchon B, Cavadore H, Guillemin S, Pain F, Weiner M, Sabbagh M, Moro C, Touchon J.

J Prev Alzheimers Dis. 2025 Aug;12(7):100185. doi: 10.1016/j.tjpad.2025.100185. Epub 2025 Apr 25.

Cholinergic therapy in Alzheimer disease

Gauthier S, Therriault J, Rosa-Neto P.

Handb Clin Neurol. 2025;211:155-159. doi: 10.1016/B978-0-443-19088-9.00015-9.

CNS muscarinic receptors and muscarinic receptor agonists in Alzheimer disease treatment

Fisher A, Levey AI.

Handb Clin Neurol. 2025;211:161-184. doi: 10.1016/B978-0-443-19088-9.00016-0.

Mitotherapy in Alzheimer's and Parkinson's diseases: A systematic review of preclinical studies

Modiri A, Hosseini L, Abolhasanpour N, Azizi H, Sadeh RN.

BMC Neurol. 2025 May 27;25(1):227. doi: 10.1186/s12883-025-04241-1.

Effect of comprehensive geriatric assessment intervention on serum S100β levels and clinical outcomes in patients with Alzheimer's disease

Wang DW, Qin XT, Wang G, Liu J, Xu YP, Tian Y, Liu B.

J Alzheimers Dis. 2025 Jul;106(2):686-694. doi: 10.1177/13872877251344544. Epub 2025 Jul 1.

Advancing Amyloid Aggregation Research: A Focus on Innovative Therapies, Molecular Modeling and Nano-Delivery Systems in Alzheimer's Disease

Hasan U, Jain H, Ali R.

Curr Drug Targets. 2025;26(11):779-798. doi: 10.2174/0113894501388678250618070927.

Targeting the redox neuroinflammatory nexus: insights into Alzheimer's and Parkinson's diseases

Dharshini LCP, Sakthivel KM, Rex KGR, Rasmi RR.

Inflammopharmacology. 2025 Jul;33(7):3885-3895. doi: 10.1007/s10787-025-01831-w. Epub 2025 Jul 2.

Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential

Yan Y, Maisenbacher M, Huang C, Fan S.

Pharmacol Res. 2025 Aug;218:107849. doi: 10.1016/j.phrs.2025.107849. Epub 2025 Jul 2.

Neuroprotective effects of essential oils in animal models of Alzheimer's and Parkinson's disease: a systematic review

Macedo ADES, Ferreira TM, Krejcová LV, Rocha FAF, da Silva JKR, Pedrosa LRR, Gomes BD.

PeerJ. 2025 Jul 10;13:e19643. doi: 10.7717/peerj.19643. eCollection 2025.

Efficacy of repetitive transcranial magnetic stimulation in cognitive impairment of neurodegenerative diseases: a systematic review and meta-analysis

Zhang Y, Xu K, Wang Y, Shen Y, Liu Z, Zhang C, Zhou Y, Lv P, Bai Y, Wang S.

BMC Neurol. 2025 Jul 17;25(1):295. doi: 10.1186/s12883-025-04292-4.

Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives

Jeong YJ, Lee HJ, Kim JS, Kim SJ, Jo U, Park JY, Jun SJ, Lee WS, Song M, Kim D, Cho G, Song JH, Hoe HS.

Med Res Rev. 2026 Jan;46(1):316-327. doi: 10.1002/med.70005. Epub 2025 Jul 31.

Next-generation CRISPR gene editing tools in the precision treatment of Alzheimer's and Parkinson's disease

Meshram HK, Gupta SK, Gupta A, Nagori K, Ajazuddin.

Ageing Res Rev. 2025 Sep;111:102851. doi: 10.1016/j.arr.2025.102851. Epub 2025 Aug 5.

Searching Heterocyclic Scaffolds Used to Treat Alzheimer's Disease: A Review

Kale MA, Faisal M.

Curr Drug Res Rev. 2025;17(2):266-281. doi: 10.2174/0125899775290026240612104933.

Glycogen synthase kinase-3: the master switch driving neurodegeneration in Alzheimer's disease and Parkinson's disease

Liu Y, Zhang J, Tang L, Yang J, Hao L, Lou F, Su J.

Arch Toxicol. 2025 Dec;99(12):4709-4735. doi: 10.1007/s00204-025-04174-1. Epub 2025 Aug 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias